Sutro shells out latest update on ovarian cancer treatment, plans for pivotal trial
Sutro Biopharma gave a Phase I update on its antibody-drug conjugate for ovarian cancer Monday afternoon, as it plans for a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
